Optimizing pharmacokinetics/pharmacodynamics of β-lactam/β-lactamase inhibitor combinations against high inocula of ESBL-producing bacteria

OBJECTIVES: Reduced in vitro β-lactam activity against a dense bacterial population is well recognized. It is commonly attributed to the presence of β-lactamase(s) and it is unknown whether the inoculum effect could be diminished by a β-lactamase inhibitor. We evaluated different β-lactam/β-lactamas...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Antimicrob Chemother
Autori principali: Tam, Vincent H, Abodakpi, Henrietta, Wang, Weiqun, Ledesma, Kimberly R, Merlau, Paul R, Chan, Katrina, Altman, Rachel, Tran, Truc T, Nikolaou, Michael, Sofjan, Amelia K
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2020
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7729384/
https://ncbi.nlm.nih.gov/pubmed/33035321
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkaa412
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi